#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic microangiopathy Neuroendocrine cell hyperplasia of infancy Congenital pseudarthrosis Familial amyotrophic lateral sclerosis Progressive supranuclear palsy Transferrin decreased Pulmonary tuberculosis Richter's syndrome Oesophageal adenocarcinoma Neoplasm Measles Corneal neovascularisation Mantle cell lymphoma stage IV Uveal melanoma Neuromyelitis optica spectrum disorder More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Basic Information Cholangitis sclerosing Soft tissue sarcoma – Treatment Synovial sarcoma – Life with Disease Adrenogenital syndrome – Diagnostics Mucous membrane pemphigoid – Life with Disease Primary hyperoxaluria – Life with Disease Mucopolysaccharidosis I – Basic Information Testicular leiomyosarcoma – Treatment Breast angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tafasitamab Eo2317 Cefalexin Sertraline Hydrochloride Al8326 Inupadenant Hydrochloride Zofenopril Calcium Ondansetron Hydrochloride VOROLANIB Ep0042 Bevacizumab Zirconium Zr-89 Afimetoran Besilate Dihydrate Umeclidinium Eftilagimod Alfa Basiliximab Azd9550 Fludarabine Phosphate Altizide Camonsertib L-Histidine Hydrochloride More therapies…

    Learn about Your Condition

    Renal cancer stage IV Hodgkin's disease recurrent Apheresis Langerhans cell sarcoma Radicular pain Amnestic disorder Substance use disorder Meniscus injury Spinal cord injury cervical Upper limb fracture Carcinoid tumour pulmonary Gastrooesophageal cancer B-cell type acute leukaemia Head injury Arteriovenous graft thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ewing’s sarcoma

  • Study of Regorafenib with Chemotherapy for Newly Diagnosed Patients with Metastatic Ewing Sarcoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    • Ewing’s sarcoma metastatic
    Investigated Drugs:
    • Regorafenib
    Denmark France Italy The Netherlands Spain

  • Study on Triptorelin for Fertility Protection in Young Women and Teenagers Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    • Ewing’s sarcoma
    • Soft tissue sarcoma
    Investigated Drugs:
    • Triptorelin
    Sweden

  • Study of Palbociclib with Drug Combinations for Children and Young Adults with Recurrent or Refractory Neuroblastoma and Ewing Sarcoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    • Ewing’s sarcoma
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Irinotecan Hydrochloride Trihydrate
    • Topotecan
    Czechia France Germany Slovakia Sweden

  • Study of Abemaciclib, Irinotecan, and Temozolomide for Patients with Relapsed or Refractory Ewing’s Sarcoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Abemaciclib
    • Irinotecan Hydrochloride
    • Temozolomide
    France Germany Italy Spain

  • Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Primitive neuroectodermal tumour
    • Ewing’s sarcoma
    • Glioma
    Investigated Drugs:
    • Lenvatinib
    Czechia France Italy Spain

  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Brain neoplasm
    • Ependymoma
    • Neuroblastoma
    Investigated Drugs:
    • Vinblastine Sulfate
    • Capecitabine
    • Cyclophosphamide
    France
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!